Articles related to ALZHEIMER'S/DEMENTIA

The lawsuit against Scott Wiesen, MD, from patient Elaine Bredehoft said this: “He was suffering from dementia and was not able to recognize long-term employees of his practice.”

“A patient who has VCID as the major cause of their dementia alongside some suspicion of an alternate neurodegenerative cause may not benefit from [anti-AD] medications as much as one who only has signs of neurodegeneration and no VCID.” – Tanav Popli, MD

“Biomarkers have moved in a healthy direction through the intervention, yet clinical responses did not see a statistically significant benefit during the duration of the trial.” — Alzheimer’s Association

The results underscore a clear message: timing and patient selection are key — and early diagnosis and intervention make the biggest difference.

For the first time, researchers found that empagliflozin, an established diabetes and heart medication, reduced markers of brain injury while restoring blood flow in critical brain regions.

Patients, with or without anemia, should be screened for elevated homocysteine or B12 deficiency because that may be one of the reversible factors in their cognitive decline.